These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35728876)

  • 1. Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.
    van Rees DJ; Bouti P; Klein B; Verkuijlen PJH; van Houdt M; Schornagel K; Tool ATJ; Venet D; Sotiriou C; El-Abed S; Izquierdo M; Guillaume S; Saura C; Di Cosimo S; Huober J; Roylance R; Kim SB; Kuijpers TW; van Bruggen R; van den Berg TK; Matlung HL
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35728876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
    Martinez Sanz P; van Rees DJ; van Zogchel LMJ; Klein B; Bouti P; Olsman H; Schornagel K; Kok I; Sunak A; Leeuwenburg K; Timmerman I; Dierselhuis MP; Kholosy WM; Molenaar JJ; van Bruggen R; van den Berg TK; Kuijpers TW; Matlung HL; Tytgat GAM; Franke K
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kindlin3-Dependent CD11b/CD18-Integrin Activation Is Required for Potentiation of Neutrophil Cytotoxicity by CD47-SIRPα Checkpoint Disruption.
    Bouti P; Zhao XW; Verkuijlen PJJH; Tool ATJ; van Houdt M; Köker N; Köker MY; Keskin O; Akbayram S; van Bruggen R; Kuijpers TW; Matlung HL; van den Berg TK
    Cancer Immunol Res; 2021 Feb; 9(2):147-155. PubMed ID: 33355195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis.
    Matlung HL; Babes L; Zhao XW; van Houdt M; Treffers LW; van Rees DJ; Franke K; Schornagel K; Verkuijlen P; Janssen H; Halonen P; Lieftink C; Beijersbergen RL; Leusen JHW; Boelens JJ; Kuhnle I; van der Werff Ten Bosch J; Seeger K; Rutella S; Pagliara D; Matozaki T; Suzuki E; Menke-van der Houven van Oordt CW; van Bruggen R; Roos D; van Lier RAW; Kuijpers TW; Kubes P; van den Berg TK
    Cell Rep; 2018 Jun; 23(13):3946-3959.e6. PubMed ID: 29949776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.
    Treffers LW; van Houdt M; Bruggeman CW; Heineke MH; Zhao XW; van der Heijden J; Nagelkerke SQ; Verkuijlen PJJH; Geissler J; Lissenberg-Thunnissen S; Valerius T; Peipp M; Franke K; van Bruggen R; Kuijpers TW; van Egmond M; Vidarsson G; Matlung HL; van den Berg TK
    Front Immunol; 2018; 9():3124. PubMed ID: 30761158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients.
    Suzuki E; Kataoka TR; Hirata M; Kawaguchi K; Nishie M; Haga H; Toi M
    BMC Cancer; 2015 Feb; 15():39. PubMed ID: 25655677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20-opsonized B cells to neutrophil killing.
    van Rees DJ; Brinkhaus M; Klein B; Verkuijlen P; Tool ATJ; Schornagel K; Treffers LW; van Houdt M; Kater AP; Vidarsson G; Gennery AR; Kuijpers TW; van Bruggen R; Matlung HL; van den Berg TK
    Blood Adv; 2022 Apr; 6(7):2156-2166. PubMed ID: 34942000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation of human neutrophil Fcγ receptors and SIRPα in antibody-dependent cellular cytotoxicity towards cancer cells.
    Treffers LW; Zhao XW; van der Heijden J; Nagelkerke SQ; van Rees DJ; Gonzalez P; Geissler J; Verkuijlen P; van Houdt M; de Boer M; Kuijpers TW; van den Berg TK; Matlung HL
    Eur J Immunol; 2018 Feb; 48(2):344-354. PubMed ID: 28952147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity.
    Bouti P; Blans C; Klein BJAM; Shome D; Nadafi R; Van Houdt M; Schornagel K; Verkuijlen PJJH; Roos V; Reijmers RM; Van Bruggen R; Kuijpers TW; Matlung HL
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.
    Cooley S; Burns LJ; Repka T; Miller JS
    Exp Hematol; 1999 Oct; 27(10):1533-41. PubMed ID: 10517495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophils as immune effector cells in antibody therapy in cancer.
    Behrens LM; van Egmond M; van den Berg TK
    Immunol Rev; 2023 Mar; 314(1):280-301. PubMed ID: 36331258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells.
    Velmurugan R; Challa DK; Ram S; Ober RJ; Ward ES
    Mol Cancer Ther; 2016 Aug; 15(8):1879-89. PubMed ID: 27226489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids.
    Beelen NA; Aberle MR; Bruno V; Olde Damink SWM; Bos GMJ; Rensen SS; Wieten L
    Front Immunol; 2023; 14():1133796. PubMed ID: 37520563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calicum microdomains form within neutrophils at the neutrophil-tumor cell synapse: role in antibody-dependent target cell apoptosis.
    Clark AJ; Diamond M; Elfline M; Petty HR
    Cancer Immunol Immunother; 2010 Jan; 59(1):149-59. PubMed ID: 19593564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.
    Collins DM; Madden SF; Gaynor N; AlSultan D; Le Gal M; Eustace AJ; Gately KA; Hughes C; Davies AM; Mahgoub T; Ballot J; Toomey S; O'Connor DP; Gallagher WM; Holmes FA; Espina V; Liotta L; Hennessy BT; O'Byrne KJ; Hasmann M; Bossenmaier B; O'Donovan N; Crown J
    Clin Cancer Res; 2021 Feb; 27(3):807-818. PubMed ID: 33122343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils.
    Behrens LM; van den Berg TK; van Egmond M
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Flow Cytometry.
    van der Haar Àvila I; Marmol P; Cany J; Kiessling R; Pico de Coaña Y
    Methods Mol Biol; 2019; 1913():181-194. PubMed ID: 30666607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine non-B, non-T NK lymphocytes have a potential antibody-dependent cellular cytotoxicity function against antibody-coated tumor cells.
    Kim Y; Lee SH; Kim CJ; Lee JJ; Yu D; Ahn S; Shin DJ; Kim SK
    BMC Vet Res; 2019 Oct; 15(1):339. PubMed ID: 31610784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
    Brandsma AM; Bondza S; Evers M; Koutstaal R; Nederend M; Jansen JHM; Rösner T; Valerius T; Leusen JHW; Ten Broeke T
    Front Immunol; 2019; 10():704. PubMed ID: 31031746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Tumor-Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal Trogocytosis.
    Singhal S; Rao AS; Stadanlick J; Bruns K; Sullivan NT; Bermudez A; Honig-Frand A; Krouse R; Arambepola S; Guo E; Moon EK; Georgiou G; Valerius T; Albelda SM; Eruslanov EB
    Cancer Res; 2024 Apr; 84(7):1029-1047. PubMed ID: 38270915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.